Copyright (c) 2009 Yahoo! Inc. All rights reserved.http://finance.yahoo.com/q/h?s=dscoLatest Financial News for Discovery Laboratories, Inc.en-usWed, 9 Dec 2009 22:30:18 Etc/GMThttp://us.news2.yimg.com/us.yimg.com/p/fi/pr/40197.gifhttp://finance.yahoo.com14417http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/e/091209/dsco8-k.htmlyahoo_finance/3153360422Wed, 9 Dec 2009 22:30:18 Etc/GMThttp://us.rd.yahoo.com/finance/external/bizj/rss/SIG=12knm8k87/*http%3A//philadelphia.bizjournals.com/philadelphia/stories/2009/11/30/daily54.html?ana=yfcpcyahoo_finance/1009060440Fri, 4 Dec 2009 23:05:17 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/e/091204/dsco8-k.htmlyahoo_finance/938575253Fri, 4 Dec 2009 21:35:50 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/pz/091204/179742.html?.v=1WARRINGTON, Pa. -- Discovery Laboratories, Inc. announced today that, on December 2, 2009, the Company received a letter from The Nasdaq Stock Market indicating that the Company is no longer in compliance with Nasdaq Listing Rule 5450 because the Company's common stock did not maintain a minimum closing bid price of $1.00 per share over the previous 30 consecutive business days.yahoo_finance/1582513302Fri, 4 Dec 2009 21:15:00 Etc/GMThttp://us.rd.yahoo.com/finance/external/tsmfe/rss/SIG=12sarf8s3/*http%3A//www.thestreet.com/_yahoo/story/10629106/1/biotech-stock-mailbag-fda-playbook.html?cm_ven=YAHOO&cm_cat=FREE&cm_ite=NAyahoo_finance/1857405035Fri, 20 Nov 2009 11:01:45 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/e/091118/dsco8-k.htmlyahoo_finance/3721522133Wed, 18 Nov 2009 21:10:32 Etc/GMThttp://us.rd.yahoo.com/finance/external/pssa/rss/SIG=132hjdam5/*http%3A//seekingalpha.com/article/173988-biomed-news-bytes-geovax-cerus-discovery-labs-neurogesx?source=yahooyahoo_finance/1516934739Wed, 18 Nov 2009 10:28:45 Etc/GMThttp://us.rd.yahoo.com/finance/external/tsmfe/rss/SIG=132ct66gb/*http%3A//www.thestreet.com/_yahoo/story/10627877/1/genzymes-termeer-worst-biotech-ceo-of-09.html?cm_ven=YAHOO&cm_cat=FREE&cm_ite=NAyahoo_finance/104375232Tue, 17 Nov 2009 17:31:11 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/pz/091117/178489.html?.v=1WARRINGTON, Pa. -- Discovery Laboratories, Inc. announced today that it has submitted to the U.S. Food and Drug Administration its proposed protocol for a Surfaxin limited clinical trial.yahoo_finance/1670849020Tue, 17 Nov 2009 12:00:00 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/q/is?s=dscoyahoo_finance/241348433Fri, 13 Nov 2009 14:05:24 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/pz/091110/178065.html?.v=1WARRINGTON, Pa. -- Discovery Laboratories, Inc. announced today that Thomas F. Miller, Ph.D., Senior Vice President of Corporate Development of Discovery Labs, will present an update on the Company's recent progress at the Lazard Capital Markets 6th Annual Healthcare Conference to be held in New York.yahoo_finance/2185769559Tue, 10 Nov 2009 21:15:00 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/e/091109/dsco10-q.htmlyahoo_finance/2331225148Mon, 9 Nov 2009 21:39:19 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/a/r/d/dsco.htmlyahoo_finance/3363230186Thu, 5 Nov 2009 14:29:31 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/e/091104/dsco8-k.htmlyahoo_finance/686034284Wed, 4 Nov 2009 22:28:02 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/pz/091104/177469.html?.v=1WARRINGTON, Pa. -- Discovery Laboratories, Inc. is providing financial results for the third quarter ended September 30, 2009. The Company will host a conference call today at 4:00 PM EST.yahoo_finance/2367224815Wed, 4 Nov 2009 13:15:00 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/pz/091104/177475.html?.v=1WARRINGTON, Pa. -- Discovery Laboratories, Inc. is providing an update on its strategic business activities and its KL4 surfactant pipeline clinical development programs. Discovery Labs is developing its proprietary KL4 surfactant technology platform to potentially significantly improve the medical outcomes of patients, from premature infants to adults, suffering debilitating respiratory diseases and conditions.yahoo_finance/1327159144Wed, 4 Nov 2009 13:00:00 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/research/earncal/20091104.html?t=dscoyahoo_finance/162652016Wed, 4 Nov 2009 12:07:27 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/pz/091030/177066.html?.v=1WARRINGTON, Pa. -- Discovery Laboratories, Inc. will be hosting a conference call on Wednesday, November 4, 2009 at 4:00 PM EST. Management will provide an update on business activities as well as financial results for the third quarter of 2009.yahoo_finance/1571778728Fri, 30 Oct 2009 20:00:00 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/pz/091027/176569.html?.v=1DALLAS -- BeaconEquity.com announces an investment report featuring biotechnology company Discovery Laboratories Inc. . The report includes financial, comparative and investment analyses, and industry information you need to know to make an educated investment decision.yahoo_finance/2328381789Tue, 27 Oct 2009 10:50:00 Etc/GMThttp://us.rd.yahoo.com/finance/external/tsmfe/rss/SIG=12rf7ieog/*http%3A//www.thestreet.com/_yahoo/story/10606562/1/discovery-labs-pump-up-the-volume.html?cm_ven=YAHOO&cm_cat=FREE&cm_ite=NAyahoo_finance/96700105Fri, 2 Oct 2009 16:44:32 Etc/GMT